{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:42:21Z","timestamp":1792748541209,"version":"4.5.0"},"reference-count":155,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632025PY09"],"award-info":[{"award-number":["2632025PY09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632025TD09"],"award-info":[{"award-number":["2632025TD09"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22577154"],"award-info":[{"award-number":["22577154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273769"],"award-info":[{"award-number":["82273769"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322062"],"award-info":[{"award-number":["82322062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504579"],"award-info":[{"award-number":["82504579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763659"],"award-info":[{"award-number":["2024M763659"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20250210"],"award-info":[{"award-number":["BX20250210"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20251577"],"award-info":[{"award-number":["BK20251577"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["1132210021"],"award-info":[{"award-number":["1132210021"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2025CXY02"],"award-info":[{"award-number":["CPU2025CXY02"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oxygen homeostasis is fundamental to cellular and organismal physiology and is primarily governed by the hypoxia-inducible factor (HIF) signaling pathway. Within this pathway, prolyl hydroxylase domain enzymes (PHDs) serve as a key oxygen sensor that regulates HIF-\u03b1 stability and thus controls hypoxic transcriptional responses. Dysregulation of this system is implicated in a broad spectrum of hypoxia-related diseases, making PHDs an important class of therapeutic targets. This perspective summarizes recent advances in PHD inhibitors, with emphasis on structural and functional differences among PHD isoforms and the predominance of PHD2 in drug discovery. We review key screening and design strategies for both carboxylate and non-carboxylate chemotypes. Current clinical progress and major challenges, such as isoform selectivity, safety concerns, and pharmacokinetic limitations, are discussed. Finally, we highlight emerging therapeutic opportunities beyond anemia, including ischemic, metabolic, and inflammatory diseases, providing a framework for precision targeting of oxygen-sensing pathways.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01656","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:01:52Z","timestamp":1791482512000},"page":"23233-23261","source":"Crossref","is-referenced-by-count":0,"title":["Insights into HIF Prolyl Hydroxylase Inhibitors: Recent Advances and Expanding Therapeutic Applications beyond Anemia"],"prefix":"10.1021","volume":"69","author":[{"given":"Limin","family":"Wei","sequence":"first","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Hu","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Lyu","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixu","family":"Qian","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Qin","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-5522","authenticated-orcid":true,"given":"Yue","family":"Wu","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-3071","authenticated-orcid":true,"given":"Xiaojin","family":"Zhang","sequence":"additional","affiliation":[{"name":"China Pharmaceutical University , , ,","place":["Nanjing, China, 211198"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026102305091504500_cit1","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1113\/jp273839","article-title":"Oxidative phosphorylation: regulation and role in cellular and tissue metabolism","volume":"595","author":"Wilson","year":"2017","journal-title":"J. Physiol."},{"key":"2026102305091504500_cit2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/antiox13030312","article-title":"Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution","volume":"13","author":"Hong","year":"2024","journal-title":"Antioxidants"},{"key":"2026102305091504500_cit3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026102305091504500_cit4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ceb.2009.08.005","article-title":"Mitochondrial reactive oxygen species regulate hypoxic signaling","volume":"21","author":"Hamanaka","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"2026102305091504500_cit5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"2026102305091504500_cit6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"2026102305091504500_cit7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s0959-437x(98)80016-6","article-title":"Hypoxia-inducible factor 1: master regulator of O2 homeostasis","volume":"8","author":"Semenza","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2026102305091504500_cit8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"2026102305091504500_cit9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"2026102305091504500_cit10","doi-asserted-by":"publisher","first-page":"38458","DOI":"10.1074\/jbc.m406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"2026102305091504500_cit12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"2026102305091504500_cit13","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"2026102305091504500_cit14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"2026102305091504500_cit15","doi-asserted-by":"publisher","first-page":"110209","DOI":"10.1016\/j.cellsig.2021.110209","article-title":"Functional and HRE motifs count analysis of induction of selected hypoxia-responsive genes by HIF-1 and HIF-2 in human umbilical endothelial cells","volume":"90","author":"Cabaj","year":"2022","journal-title":"Cell Signal."},{"key":"2026102305091504500_cit16","doi-asserted-by":"publisher","first-page":"12673","DOI":"10.1038\/ncomms12673","article-title":"Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Nat. Commun."},{"key":"2026102305091504500_cit17","doi-asserted-by":"publisher","first-page":"17871","DOI":"10.1021\/jacs.5c01935","article-title":"Light-induced, lysine-targeting irreversible covalent inhibition of the human oxygen sensing hydroxylase factor inhibiting HIF (FIH)","volume":"147","author":"Wu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026102305091504500_cit18","doi-asserted-by":"publisher","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"McDonough","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026102305091504500_cit19","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1074\/jbc.m707411200","article-title":"Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases","volume":"283","author":"Flashman","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/hp.s174655","article-title":"Born to sense: biophysical analyses of the oxygen sensing prolyl hydroxylase from the simplest animal Trichoplax adhaerens","volume":"6","author":"Lippl","year":"2018","journal-title":"Hypoxia"},{"key":"2026102305091504500_cit21","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.cbpa.2024.102428","article-title":"Biochemistry of the hypoxia-inducible factor hydroxylases","volume":"79","author":"Fiorini","year":"2024","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2026102305091504500_cit22","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"key":"2026102305091504500_cit23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1242\/jcs.00318","article-title":"Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing","volume":"116","author":"Metzen","year":"2003","journal-title":"J. Cell Sci."},{"key":"2026102305091504500_cit24","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1182\/blood-2007-09-114561","article-title":"Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins","volume":"111","author":"Takeda","year":"2008","journal-title":"Blood"},{"key":"2026102305091504500_cit25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/circulationaha.107.701516","article-title":"Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system","volume":"116","author":"Takeda","year":"2007","journal-title":"Circulation"},{"key":"2026102305091504500_cit26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.str.2009.06.002","article-title":"Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases","volume":"17","author":"Chowdhury","year":"2009","journal-title":"Structure"},{"key":"2026102305091504500_cit27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jinorgbio.2006.01.024","article-title":"Structural studies on 2-oxoglutarate oxygenases and related double-stranded \u03b2-helix fold proteins","volume":"100","author":"Clifton","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"2026102305091504500_cit28","doi-asserted-by":"publisher","first-page":"08.07.552357","DOI":"10.1101\/2023.08.07.552357","article-title":"Gas tunnel engineering of prolyl hydroxylase reprograms hypoxia signaling in cells","volume":"63","author":"Windsor","year":"2024","journal-title":"bioRxiv."},{"key":"2026102305091504500_cit29","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/anie.200805427","article-title":"Evidence for a stereoelectronic effect in human oxygen sensing","volume":"48","author":"Loenarz","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"2026102305091504500_cit30","doi-asserted-by":"publisher","first-page":"30772","DOI":"10.1074\/jbc.m304982200","article-title":"Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor","volume":"278","author":"Hirsila\u0308","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/bj20061151","article-title":"Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay","volume":"401","author":"Ehrismann","year":"2007","journal-title":"Biochem. J."},{"key":"2026102305091504500_cit32","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1021\/jm400386j","article-title":"Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses","volume":"56","author":"Rabinowitz","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit33","doi-asserted-by":"publisher","first-page":"11880","DOI":"10.1021\/ja2040909","article-title":"A more reactive trigonal-bipyramidal high-spin oxoiron (IV) complex with a cis-labile site","volume":"133","author":"England","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"2026102305091504500_cit34","doi-asserted-by":"publisher","first-page":"7651","DOI":"10.1039\/c7sc02103h","article-title":"Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials","volume":"8","author":"Yeh","year":"2017","journal-title":"Chem. Sci."},{"key":"2026102305091504500_cit35","doi-asserted-by":"publisher","first-page":"26162","DOI":"10.1038\/s41598-024-75761-y","article-title":"Human prolyl hydroxylase domain 2 reacts with O(2) and 2-oxoglutarate to enable formation of inactive Fe(III).2OG.hypoxia-inducible-factor \u03b1 complexes","volume":"14","author":"Fiorini","year":"2024","journal-title":"Sci. Rep."},{"key":"2026102305091504500_cit36","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1158\/1078-0432.ccr-10-1408","article-title":"Hypoxia inducible factor 1\u03b1 and hypoxia inducible factor 2\u03b1 play distinct and functionally overlapping roles in oral squamous cell carcinoma","volume":"16","author":"Zhu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"2026102305091504500_cit37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J."},{"key":"2026102305091504500_cit38","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/mcb.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"2026102305091504500_cit39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/jci200421086","article-title":"Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis","volume":"114","author":"Karhausen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2026102305091504500_cit40","doi-asserted-by":"publisher","first-page":"649463","DOI":"10.3389\/fimmu.2021.649463","article-title":"Tiliroside ameliorates ulcerative colitis by restoring the M1\/M2 macrophage balance via the HIF-1\u03b1\/glycolysis pathway","volume":"12","author":"Zhuang","year":"2021","journal-title":"Front. Immunol."},{"key":"2026102305091504500_cit41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nm721","article-title":"Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice","volume":"8","author":"Compernolle","year":"2002","journal-title":"Nat. Med."},{"key":"2026102305091504500_cit42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/cvr\/cvm035","article-title":"Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha","volume":"77","author":"Cai","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"2026102305091504500_cit43","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1182\/blood-2015-10-677138","article-title":"Adult hematopoietic stem cells lacking Hif-1\u03b1 self-renew normally","volume":"127","author":"Vukovic","year":"2016","journal-title":"Blood"},{"key":"2026102305091504500_cit44","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2013-02-484923","article-title":"Hif-2\u03b1 is not essential for cell-autonomous hematopoietic stem cell maintenance","volume":"122","author":"Guitart","year":"2013","journal-title":"Blood"},{"key":"2026102305091504500_cit45","doi-asserted-by":"publisher","first-page":"11032","DOI":"10.1074\/jbc.m208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","article-title":"The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy","volume":"14","author":"Albadari","year":"2019","journal-title":"Expert. Opin. Drug Discov."},{"key":"2026102305091504500_cit47","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1074\/jbc.m117.805655","article-title":"Hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity","volume":"292","author":"Ma","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3892\/ol.2026.1557","article-title":"Hypoxia-inducible factors: Regulatory functions and status as a therapeutic target in gastric cancer (Review)","volume":"31","author":"Xu","year":"2026","journal-title":"Oncol. Lett."},{"key":"2026102305091504500_cit49","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.kint.2017.03.008","article-title":"Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor","volume":"92","author":"Kiriakidis","year":"2017","journal-title":"Kidney Int."},{"key":"2026102305091504500_cit50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/cells8030207","article-title":"Hypoxia and hypoxia-inducible factors in kidney injury and repair","volume":"8","author":"Shu","year":"2019","journal-title":"Cells"},{"key":"2026102305091504500_cit51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40620-024-02152-x","article-title":"The role of hypoxia-inducible factors 1 and 2 in the pathogenesis of diabetic kidney disease","volume":"38","author":"Kleibert","year":"2024","journal-title":"J. Nephrol."},{"key":"2026102305091504500_cit52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"2026102305091504500_cit53","doi-asserted-by":"publisher","first-page":"110456","DOI":"10.1016\/j.cclet.2024.110456","article-title":"New techniques and strategies in drug discovery (2020\u22122024 update)","volume":"36","author":"Gong","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"2026102305091504500_cit54","doi-asserted-by":"publisher","first-page":"0","DOI":"10.48130\/targetome-0026-0017","article-title":"OPTAR: a computational tool for target discovery based on disease correlation inference from literature of interacting proteins","volume":"2","author":"Yuan","year":"2026","journal-title":"Targetome"},{"key":"2026102305091504500_cit55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0076-6879(82)82067-3","article-title":"Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes","volume":"82","author":"Kivirikko","year":"1982","journal-title":"Methods Enzymol."},{"key":"2026102305091504500_cit56","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s1570-0232(03)00163-6","article-title":"Quantitative determination of free intracellular \u03b1-keto acids in neutrophils","volume":"789","author":"Mu\u0308hling","year":"2003","journal-title":"J. Chromatogr. B."},{"key":"2026102305091504500_cit57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ab.2004.09.019","article-title":"A fluorescence-based assay for 2-oxoglutarate-dependent oxygenases","volume":"336","author":"McNeill","year":"2005","journal-title":"Anal. Biochem."},{"key":"2026102305091504500_cit58","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1021\/cb400088q","article-title":"Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases","volume":"8","author":"Chowdhury","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"2026102305091504500_cit59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/abio.1993.1043","article-title":"A high-performance liquid chromatography assay for threonine\/serine dehydratase","volume":"208","author":"Singh","year":"1993","journal-title":"Anal. Biochem."},{"key":"2026102305091504500_cit60","doi-asserted-by":"publisher","first-page":"23031","DOI":"10.1074\/jbc.272.37.23031","article-title":"Characterization of alpha-ketoglutarate-dependent taurine dioxygenase from Escherichia coli","volume":"272","author":"Eichhorn","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2026102305091504500_cit61","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1021\/jm901680b","article-title":"Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches","volume":"53","author":"Rose","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit62","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1021\/cc100073a","article-title":"Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1\u03b1 prolyl hydroxylases-1, -2, and -3 with altered selectivity","volume":"12","author":"Murray","year":"2010","journal-title":"J. Comb. Chem."},{"key":"2026102305091504500_cit63","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/acsmedchemlett.5b00394","article-title":"Affinity-based fluorescence polarization assay for high-throughput screening of prolyl hydroxylase 2 inhibitors","volume":"6","author":"Lei","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"2026102305091504500_cit64","doi-asserted-by":"publisher","first-page":"14199","DOI":"10.1039\/d0cc06353c","article-title":"A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation","volume":"56","author":"Li","year":"2020","journal-title":"Chem. Commun."},{"key":"2026102305091504500_cit65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ab.2008.09.052","article-title":"Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology","volume":"384","author":"Dao","year":"2009","journal-title":"Anal. Biochem."},{"key":"2026102305091504500_cit66","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.bmcl.2008.06.031","article-title":"Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation","volume":"18","author":"Tegley","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026102305091504500_cit67","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1021\/acschembio.6b00330","article-title":"A genetically encoded FRET sensor for hypoxia and prolyl hydroxylases","volume":"11","author":"Youssef","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"2026102305091504500_cit68","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1021\/jm201542d","article-title":"1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1\u22123 (HIF PHD1\u22123) for the treatment of anemia","volume":"55","author":"Vachal","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit69","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1021\/acs.jmedchem.6b01242","article-title":"Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia","volume":"59","author":"Debenham","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1021\/jm301583m","article-title":"Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors","volume":"56","author":"Leung","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit71","doi-asserted-by":"publisher","first-page":"971795","DOI":"10.3389\/fphar.2022.971795","article-title":"Roxadustat: not just for anemia","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"2026102305091504500_cit72","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.drudis.2020.04.017","article-title":"The prolyl hydroxylase inhibitor roxadustat: paradigm in drug discovery and prospects for clinical application beyond anemia","volume":"25","author":"Su","year":"2020","journal-title":"Drug Discov. Today"},{"key":"2026102305091504500_cit73","doi-asserted-by":"publisher","first-page":"D297","DOI":"10.1093\/nar\/gkt1208","article-title":"MMDB and VAST+: tracking structural similarities between macromolecular complexes","volume":"42","author":"Madej","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2026102305091504500_cit74","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13018-022-03162-w","article-title":"Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1\u03b1 and activating the Wnt\/\u03b2-catenin signaling pathway","volume":"17","author":"Li","year":"2022","journal-title":"J. Orthop. Surg. Res"},{"key":"2026102305091504500_cit75","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: first global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"2026102305091504500_cit76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1124\/jpet.122.001126","article-title":"Preclinical characterization of Vadadustat (AKB-6548), an oral small molecule hypoxia-inducible factor prolyl-4-hydroxylase inhibitor, for the potential treatment of renal anemia","volume":"383","author":"Zuk","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026102305091504500_cit77","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40265-020-01383-z","article-title":"Vadadustat: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"2026102305091504500_cit78","doi-asserted-by":"publisher","first-page":"25569","DOI":"10.1021\/acs.jmedchem.5c02719","article-title":"Discovery of 3-(arylamido) pyrazolopyridine HIF-2\u03b1 agonists and a codrug strategy with prolyl hydroxylase inhibition for synergistic treatment of renal anemia","volume":"68","author":"Gao","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit79","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.1021\/acs.jmedchem.6c01014","article-title":"A near-infrared photoactivatable, brain-penetrant prodrug of the prolyl hydroxylase inhibitor Vadadustat for neuroprotection in ischemic stroke","volume":"69","author":"Li","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit80","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1021\/acs.jmedchem.9b00688","article-title":"Photoactivatable prolyl hydroxylase 2 inhibitors for stabilizing the hypoxia-inducible factor with light","volume":"62","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit81","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.1021\/acs.jmedchem.0c01161","article-title":"Discovery of clinical candidate (5-(3-(4-chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an orally bioavailable prolyl hydroxylase inhibitor for the treatment of anemia","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit82","doi-asserted-by":"publisher","first-page":"114479","DOI":"10.1016\/j.ejmech.2022.114479","article-title":"Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia","volume":"238","author":"Su","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026102305091504500_cit83","doi-asserted-by":"publisher","first-page":"8545","DOI":"10.1021\/acs.jmedchem.3c00231","article-title":"Preferred conformation-guided discovery of potent and orally active HIF prolyl hydroxylase 2 inhibitors for the treatment of anemia","volume":"66","author":"Wu","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40265-020-01444-3","article-title":"Enarodustat: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"2026102305091504500_cit85","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1021\/acsmedchemlett.7b00404","article-title":"Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia","volume":"8","author":"Ogoshi","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"2026102305091504500_cit86","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400504","article-title":"Crystallographic and selectivity studies on the approved HIF prolyl hydroxylase inhibitors desidustat and Enarodustat","volume":"19","author":"Corner","year":"2024","journal-title":"ChemMedChem"},{"key":"2026102305091504500_cit87","doi-asserted-by":"publisher","first-page":"1459425","DOI":"10.3389\/fneph.2024.1459425","article-title":"Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia","volume":"4","author":"Joharapurkar","year":"2024","journal-title":"Front. Nephrol."},{"key":"2026102305091504500_cit88","doi-asserted-by":"publisher","first-page":"129799","DOI":"10.1016\/j.bmcl.2024.129799","article-title":"Discovery of DS44470011: an oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia","volume":"108","author":"Fukuda","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026102305091504500_cit89","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/cmdc.201700783","article-title":"Discovery of Molidustat (BAY 85-3934): a small-molecule oral HIF-Prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia","volume":"13","author":"Beck","year":"2018","journal-title":"ChemMedChem"},{"key":"2026102305091504500_cit90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132004","article-title":"Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS One"},{"key":"2026102305091504500_cit91","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/cmdc.202100133","article-title":"Structural basis of prolyl hydroxylase domain inhibition by Molidustat","volume":"16","author":"Figg","year":"2021","journal-title":"ChemMedChem"},{"key":"2026102305091504500_cit92","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1016\/j.bmc.2013.08.046","article-title":"Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors","volume":"21","author":"Deng","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"2026102305091504500_cit93","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/cmdc.201900557","article-title":"Structure-activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors","volume":"15","author":"Holt-Martyn","year":"2020","journal-title":"ChemMedChem"},{"key":"2026102305091504500_cit94","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s43018-024-00761-w","article-title":"The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1\u03b1 and compromises development and progression of acute myeloid leukemia","volume":"5","author":"Lawson","year":"2024","journal-title":"Nat. Cancer"},{"key":"2026102305091504500_cit95","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","article-title":"druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico","volume":"14","author":"Kadurin","year":"2017","journal-title":"Mol. Pharm."},{"key":"2026102305091504500_cit96","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1021\/acs.jcim.7b00690","article-title":"Reinforced adversarial neural computer for de novo molecular design","volume":"58","author":"Lane","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"2026102305091504500_cit97","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1021\/acs.jmedchem.7b00352","article-title":"1,2,4-Triazolo-[1,5-a]pyridine HIF prolylhydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction","volume":"60","author":"Ahmed","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrd.2015.19","article-title":"Towards a hit for every target","volume":"15","author":"Rees","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102305091504500_cit99","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202211510","article-title":"In situ inhibitor synthesis and screening by fluorescence polarization: an efficient approach for accelerating drug discovery","volume":"134","author":"Li","year":"2022","journal-title":"Angew. Chem. Weinheim Bergstr. Ger."},{"key":"2026102305091504500_cit100","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1073\/pnas.94.6.2106","article-title":"Virtual combinatorial libraries: dynamic generation of molecular and supramolecular diversity by self-assembly","volume":"94","author":"Huc","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026102305091504500_cit101","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1126\/science.287.5460.1947","article-title":"Techview: drug discovery. Integrating combinatorial synthesis and bioassays","volume":"287","author":"Rademann","year":"2000","journal-title":"Science"},{"key":"2026102305091504500_cit102","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1038\/s41467-019-10627-w","article-title":"Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library","volume":"10","author":"Canal-Marti\u0301n","year":"2019","journal-title":"Nat. Commun."},{"key":"2026102305091504500_cit103","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl Hydroxylase Inhibitors: A breakthrough in the therapy of anemia associated with chronic diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit104","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1021\/acs.jmedchem.9b00917","article-title":"Designing around structural alerts in drug discovery","volume":"63","author":"Kalgutkar","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit105","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/nejmoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit106","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/nejmoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit107","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"2026102305091504500_cit108","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s40262-024-01417-9","article-title":"Integrated population pharmacokinetics of daprodustat in patients with chronic kidney disease with anemia","volume":"63","author":"Mahar","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"2026102305091504500_cit109","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/nejmoa2113379","article-title":"Daprodustat for the treatment of anemia in patients undergoing dialysis","volume":"385","author":"Singh","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit110","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/nejmoa2035938","article-title":"Vadadustat in patients with anemia and non-dialysis-dependent CKD","volume":"384","author":"Chertow","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit111","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2215\/cjn.02440222","article-title":"HIF-PHIs for anemia management in CKD: potential and uncertainty ASCEND","volume":"17","author":"McCallum","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2026102305091504500_cit112","doi-asserted-by":"publisher","first-page":"1406588","DOI":"10.3389\/fphar.2024.1406588","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis","volume":"15","author":"Ren","year":"2024","journal-title":"Front. Pharmacol."},{"key":"2026102305091504500_cit113","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/asn.2019060623","article-title":"Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral Roxadustat in CKD patients with anemia on hemodialysis in Japan","volume":"31","author":"Akizawa","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"2026102305091504500_cit114","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ph18101566","article-title":"Safety of Roxadustat in chronic kidney disease patients: an updated systematic review and meta-nalysis","volume":"18","author":"Marti\u0301nez-Miguel","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2026102305091504500_cit115","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.kisu.2020.12.002","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease","volume":"11","author":"Haase","year":"2021","journal-title":"Kidney Int. Suppl."},{"key":"2026102305091504500_cit116","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/jch.14186","article-title":"Chronic kidney disease: definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk","volume":"23","author":"Wilson","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"2026102305091504500_cit117","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","article-title":"Targeting hypoxia-inducible factors: therapeutic opportunities and challenges","volume":"23","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102305091504500_cit118","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of HIF on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"2026102305091504500_cit119","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis, isk-stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am. J. Hematol."},{"key":"2026102305091504500_cit120","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1748-717x-5-107","article-title":"Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21","volume":"5","author":"El-Khatib","year":"2010","journal-title":"Radiat. Oncol."},{"key":"2026102305091504500_cit121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"key":"2026102305091504500_cit122","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/nejmoa2103425","article-title":"Belzutifan for renal cell carcinoma in von hippel-lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit123","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/s1471-4914(02)02317-1","article-title":"HIF-1\u03b1 and tumor progression: pathophysiology and therapeutics","volume":"8","author":"Semenza","year":"2002","journal-title":"Trends Mol. Med."},{"key":"2026102305091504500_cit124","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/cm9.0000000000003470","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors in treatment of anemia with chronic disease","volume":"138","author":"Li","year":"2025","journal-title":"Chin. Med. J."},{"key":"2026102305091504500_cit125","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41587-024-02503-w","article-title":"Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor","volume":"43","author":"Fu","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"2026102305091504500_cit126","doi-asserted-by":"publisher","first-page":"izag006.011","DOI":"10.1093\/ibd\/izag006.011","article-title":"Preclinical toxicology evaluation of ism5411: 13-week oral administration in rats and beagle dogs","volume":"32","author":"Lin","year":"2026","journal-title":"Gastroenterology"},{"key":"2026102305091504500_cit127","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","article-title":"Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for parkinson\u2019s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function","volume":"10","author":"Li","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"2026102305091504500_cit128","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12974-024-03070-2","article-title":"Hypoxia inducible factor-1\u03b1 regulates microglial innate immune memory and the pathology of Parkinson\u2019s disease","volume":"21","author":"Dong","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"2026102305091504500_cit129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13287-025-04626-6","article-title":"Glycyrrhizic acid combined with human adipose-derived MSCs synergistically alleviates the MPP+\/MPTP-induced parkinson\u2019s disease by inducing autophagy through PI3K\/AKT\/HIF-1\u03b1 pathway","volume":"16","author":"Yu","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"2026102305091504500_cit130","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/ndt\/gfx011","article-title":"Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China","volume":"32","author":"Chen","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"2026102305091504500_cit131","doi-asserted-by":"publisher","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026102305091504500_cit132","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s1875-5364(25)60821-1","article-title":"A comprehensive review on wedelolactone: natural sources, total synthesis, and pharmacological activities","volume":"23","author":"Cai","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"2026102305091504500_cit133","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1038\/s41598-023-42903-7","article-title":"The neuroprotective effects of FG-4592, a hypoxia-inducible factor-prolyl hydroxylase inhibitor, against oxidative stress induced by alpha-synuclein in N2a cells","volume":"13","author":"Fujimaki","year":"2023","journal-title":"Sci Rep"},{"key":"2026102305091504500_cit134","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40360-023-00682-x","article-title":"Core decompression combined with local DFO administration loaded on polylactic glycolic acid scaffolds for the treatment of osteonecrosis of the femoral head: a pilot study","volume":"24","author":"Gharanizadeh","year":"2023","journal-title":"BMC Pharmacol. Toxicol."},{"key":"2026102305091504500_cit135","doi-asserted-by":"publisher","first-page":"3120458","DOI":"10.1155\/2020\/3120458","article-title":"Combined pharmacotherapy with alendronate and desferoxamine regulate the bone resorption and bone regeneration for preventing glucocorticoids-induced osteonecrosis of the femoral head","volume":"2020","author":"Sheng","year":"2020","journal-title":"BioMed Res. Int."},{"key":"2026102305091504500_cit136","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1535370214553906","article-title":"The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads","volume":"240","author":"Li","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"2026102305091504500_cit137","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1056\/NEJM198007103030215","article-title":"Cisplatin-induced anemia","volume":"303","author":"Kuzur","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"2026102305091504500_cit138","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamaoncol.2025.0756","article-title":"Intravenous magnesium and cisplatin-associated acute kidney injury","volume":"11","author":"Gupta","year":"2025","journal-title":"JAMA Oncol"},{"key":"2026102305091504500_cit139","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"2026102305091504500_cit140","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000078452","article-title":"Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity","volume":"24","author":"Mishra","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"2026102305091504500_cit141","doi-asserted-by":"publisher","first-page":"114115","DOI":"10.1016\/j.ejmech.2022.114115","article-title":"Novel PHD2\/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury","volume":"230","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026102305091504500_cit142","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00204-022-03285-3","article-title":"Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe?","volume":"96","author":"The\u0301venod","year":"2022","journal-title":"Arch. Toxicol."},{"key":"2026102305091504500_cit143","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/0886022x.2021.1915801","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia\/reperfusion injury by inhibiting inflammation","volume":"43","author":"Miao","year":"2021","journal-title":"Ren. Fail."},{"key":"2026102305091504500_cit144","doi-asserted-by":"publisher","DOI":"10.1126\/science.adw8526","article-title":"Species-specific oxygen sensing governs the initiation of vertebrate limb regeneration","volume":"392","author":"Tsissios","year":"2026","journal-title":"Science"},{"key":"2026102305091504500_cit145","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ajh.21569","article-title":"Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease","volume":"85","author":"Fitzhugh","year":"2010","journal-title":"Am. J. Hematol."},{"key":"2026102305091504500_cit146","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ajh.23683","article-title":"Factors associated with survival in a contemporary adult sickle cell disease cohort","volume":"89","author":"Elmariah","year":"2014","journal-title":"Am. J. Hematol."},{"key":"2026102305091504500_cit147","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.brci.2026.100077","article-title":"Daprodustat augments red blood cell and \u03b3-globin production in models of sickle cell disease","volume":"2","author":"Sharma","year":"2026","journal-title":"Blood RCI"},{"key":"2026102305091504500_cit148","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70086","article-title":"HIF-prolyl hydroxylase inhibitor desidustat increases pyruvate kinase activity and reduces oxidative stress in red blood cells, causes erythrocytosis in thalassaemic mice, and reduces sickling in sickle cell patient\u2019s blood","volume":"86","author":"Patel","year":"2025","journal-title":"Drug Dev. Res."},{"key":"2026102305091504500_cit149","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s13063-026-09721-4","article-title":"Study protocol for a randomized, double-blind, placebo-controlled clinical trial of desidustat oral tablet in sickle cell disease: a phase IIa proof-of-concept evaluation","volume":"27","author":"Gangwar","year":"2026","journal-title":"Trials"},{"key":"2026102305091504500_cit150","doi-asserted-by":"publisher","first-page":"130548","DOI":"10.1016\/j.bbagen.2023.130548","article-title":"Roxadustat ameliorates experimental colitis in mice by regulating macrophage polarization through increasing HIF level","volume":"1868","author":"Kong","year":"2024","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"2026102305091504500_cit151","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s40001-023-01179-3","article-title":"Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria","volume":"28","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"2026102305091504500_cit152","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2506647123","article-title":"Hypoxia inducible factors regulate pneumovirus replication by enhancing innate immune sensing","volume":"123","author":"Ha","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026102305091504500_cit153","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1182\/blood-2003-02-0448","article-title":"The HIF family member EPAS1\/HIF-2\u03b1 is required for normal hematopoiesis in mice","volume":"102","author":"Scortegagna","year":"2003","journal-title":"Blood"},{"key":"2026102305091504500_cit154","doi-asserted-by":"publisher","first-page":"9777","DOI":"10.1021\/acs.jmedchem.5c00586","article-title":"Derivatives of the clinically used HIF prolyl hydroxylase inhibitor desidustat are efficient inhibitors of human \u03b3-butyrobetaine hydroxylase","volume":"68","author":"Corner","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026102305091504500_cit155","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500682","article-title":"Profiling inhibitor scaffolds for the cancer target jumonji-C domain-containing protein 6","volume":"20","author":"Corner","year":"2025","journal-title":"ChemMedChem"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01656","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23233\/68791931\/jm6c01656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23233\/68791931\/jm6c01656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:10:12Z","timestamp":1792746612000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23233\/5447257\/Insights-into-HIF-Prolyl-Hydroxylase-Inhibitors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":155,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,8]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01656","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}